幹細胞多能性遺伝子Klf4とOct4は,末期性動脈硬化損傷の病原性において重要な複合性SMC現象変化を調節する.
PubMedで要約を見る
まとめ
この要約は機械生成です。高度な動脈硬化症の滑らかな筋肉細胞 (SMC) は,様々な有害な細胞タイプに移行して,有意な可塑性を示す. Klf4はこれらの移行を調節し,プラークの安定性に影響を与え,カルシフィケーションに潜在的に貢献します.
科学分野
- 心血管生物学
- 細胞 と 分子 医学
- 動脈硬化に関する研究
背景
- 進行性動脈硬化病変は,心筋梗塞や脳卒中につながる世界的な健康上の重大な脅威です.
- 末期性動脈硬化症におけるプラークの安定性を駆動する細胞組成とメカニズムの理解は限られている.
研究 の 目的
- 進行したヒトとマウスの動脈硬化病変内のすべての細胞タイプを包括的に特定し,特徴づけること.
- プラーク病原性における滑らかな筋肉細胞 (SMC) 派生細胞の起源と機能的可塑性を解明する.
- SMCの表型変異の調節におけるKlf4の役割とその病変の発生への影響を調査する.
主な方法
- 人間の頸動脈末関節切除サンプルとネズミの動脈硬化病変の単細胞RNA配列解析
- マウスの内皮とSMC系統の追跡,二重系統の追跡モデルを含む.
- 遺伝子調節を分析するためにクロマチン免疫降水配列 (ChIP-seq) と大量RNA配列.
主要な成果
- マウスとヒトの動脈硬化病変の間で顕著なトランスクリプトミックの類似性が観察されました.
- SMCから派生した細胞は,コンドロサイトのような集団と"先駆者"細胞のフェノタイプを含む独特のクラスターを形成し,広範なフェノタイプの可塑性を示した.
- SMC特有のKlf4ノックアウトは,Klf4の調節作用を強調して,ゲノムシグネチャを著しく変化させ,コンドロサイト型および骨質性フェノタイプを減少させた.
結論
- 先進性動脈硬化性病変におけるSMC由来細胞は,これまで理解されていたより大きな現象性可塑性を示す.
- Klf4は,Lgals3+骨性細胞を含む複数のフェノタイプへのSMCの移行を調節する上で重要な役割を果たします.
- これらのKlf4依存型変異は,末期性動脈硬化症のプラーク病変に有害であり,カルシフィケーションと不安定化に潜在的に寄与する可能性があります.
関連する概念動画
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

